Monday, November 7, 2011

Vietnam: Cancellation lot of drugs against influenza A-H5N1 worth 280 billion

Updated: 07-11-2011 10:02:52

This is suggested by the Health Ministry in the Prime Minister to report on the results of inspection of the drug substance and drug Tamiflu Oseltamivir phosphate influenza A/H5N1 epidemic.

This is suggested by the Health Ministry in the Prime Minister to report on the results of inspection of the drug substance and drug Tamiflu Oseltamivir phosphate influenza A/H5N1 epidemic.

On drug treatment plots than 9.7 million active ingredient Oseltamivir capsules 75mg used against A/H5N1 flu, the Health Ministry said that the research, the active ingredient oseltamivir phosphate recovered from finished drugs have expired use is not feasible, not effective on economy and science.

Ability to recover from drugs active ingredient has expired, the Ministry of Health has authorized a joint venture Company Limited Stada Vietnam to work with manufacturers Oseltamivir phosphate materials in India.

Thereby, the joint venture Company Limited announced Stada Vietnam, the ability to recover from the drug substance has expired only 30%, especially the purity of the recycled materials will not guarantee safety when applied to humans.

Based on the comments above, the Party Civil Affairs Ministry of Health has decided not to recycle, destroy all the proposed lots more than 9.7 million drug Oseltamivir 75mg capsules, worth about $ 280 billion for this drug Lot limited use to May 2 / 2009 and May 3 / 2009.

As known, before the evolution of influenza A/H5N1 in late 2005, the Government has directed the Ministry of Health to urgently reserve and production of Tamiflu medicine Oseltamivir phosphate ingredients for active prevention.

In relation to this incident by the Health Ministry, the Prime Minister recently concluded that corruption is not detected.

According to Prime Minister Nguyen Tan Dung, the projected H5N1 influenza situation and proceed with high reserve drugs is necessary to promptly deal with the worst situation possible. However, in the process of implementing the plan at the Ministry of Health has happened a number of errors, defects on the order and procedures. In this regard, the Ministry of Health should review and draw experience.

Also, so far not found a negative corruption in the use of reserve funds for drug production and drug Tamiflu.

About the company involved in manufacturing the drug in this case, the Prime Minister also delivered the relevant amount determined by the Company 2.846.000USD STADA Import / Export Hong Kong's transfer to the Company Stada Vietnam, and the company Imexpharm PYMEPHARCO company is due to discounts or support material loss and on the basis that the proposed treatment as prescribed by law.

The Prime Minister also asked the Health Ministry to recover the amount of nearly 166 million from the four companies involved in production plans have not been into drugs for bioequivalence testing that contains the active ingredient oseltamivir phosphate.


No comments: